Unlock Exclusive Discounts & Flash Sales! Click Here to Join the Deals on Every Wednesday!
Surfactants stabilize biomolecules against interfacial stress and/or prevent adsorption. Polysorbate 20, polysorbate 80 and poloxamer 189 are so far the only FDA-approved surfactants for parenteral application in biopharmaceutical products. Besides their benefits, it is common knowledge that surfactants, such as polysorbates, are prone to degradation by hydrolysis and oxidation. While such degradation can directly affect the function of the surfactant, it could also lead to the formation of insoluble fatty acid-related particles over time - a potential issue for the safety and efficacy of a biopharmaceutical drug product.